Exchange: NASDAQ·Updated 07:30 PM EDT
ATHE logo

ATHE Alterity Therapeutics Ltd - ADR

$4.46
$0.02
(0.44%)
Today
Closed $4.54
$0.0843
(1.86%)
After Hours
Mkt Cap$83.5M
Vol4,563.00

About ATHE

Alterity Therapeutics Ltd. engages in the business of research and development of therapeutic drugs designed to treat neurodegenerative diseases, focusing on Parkinsonian and other movement disorders. Its lead candidate, ATH434, is an oral small molecule drug designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. The company was founded by Geoffrey Paul Kempler on November 11, 1997 and is headquartered in Melbourne, Australia.
50

Neutral Sentiment

How do you feel about ATHE?

Advertisement|Remove ads.